Skip to main content
SpringerLink
Log in

The Molecular Basis of Von Hippel-Lindau Disease

  • Minireviews
  • Published:
Molecular Medicine Aims and scope Submit manuscript

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. McKusick VA (1992) Mendelian Inheritance in Man. The Johns Hopkins University Press, Baltimore.

    Google Scholar 

  2. Maher ER, Yates JRW, Harries R, et al. (1990) Clinical features and natural history of von Hippel-Lindau disease. Q. J. Med. 77: 1151–1163.

    Article  CAS  PubMed  Google Scholar 

  3. Maher ER, Yates JRW, Ferguson-Smith MA (1990) Statistical analysis of the two-stage mutation model in von Hippel-Lindau disease, and in sporadic cerebellar hemangioblastoma and renal cell carcinoma. J. Med. Genet. 27: 311–314.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  4. Latif F, Tory K, Gnarra J, et al. (1993) Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 260: 1317–1320.

    Article  CAS  PubMed  Google Scholar 

  5. Gnarra JR, Duan DR, Weng Y, et al. (1996) Molecular cloning of the von Hippel-Lindau tumor suppressor gene and its role in renal cell carcinoma [review]. Biochim. Biophys. Acta 1242: 201–210.

    PubMed  Google Scholar 

  6. Iliopoulos O, Kibel A, Gray S, et al. (1995) Tumor suppression by the human von Hippel-Lindau gene product. Nat. Med. 1: 822–826.

    Article  CAS  PubMed  Google Scholar 

  7. Renbaum P, Duh F-M, Latif F, et al. (1996) Isolation and characterization of the full-length 3′ untranslated region of the human von Hippel-Lindau tumor suppressor gene. Hum. Genet. 98: 666–671.

    Article  CAS  PubMed  Google Scholar 

  8. Duan DR, Humphrey JS, Chen DYT, et al. (1995) Characterization of the VHL tumor suppressor gene product: Localization, complex formation, and the effect of natural inactivating mutations. Froc. Natl. Acad. Sci. U.S.A. 92: 6495–6499.

    Google Scholar 

  9. Gao J, Naglich JG, Laidlaw J, et al. (1995) Cloning and characterization of a mouse gene with homology to the human von Hippel-Lindau disease tumor suppressor gene: Implications for the potential organization of the human von Hippel-Lindau disease gene. Cancer Res. 55: 743–747.

    PubMed  CAS  Google Scholar 

  10. Chen F, Kishida T, Yao M, et al. (1995) Germ line mutations in the von Hippel-Lindau disease tumor suppressor gene: Correlations with phenotype. Hum. Mutat. 5: 66–75.

    Article  CAS  PubMed  Google Scholar 

  11. Crossey PA, Richards FM, Foster K, et al. (1994) Identification of intragenic mutations in the von Hippel-Lindau disease tumor suppressor gene and correlation with disease phenotype. Hum. Mol. Gen. 3: 1303–1308.

    Article  CAS  PubMed  Google Scholar 

  12. Whaley JM, Naglich J, Gelbert L, et al. (1994) Germ-line mutations in the von Hippel-Lindau tumor suppressor gene are similar to somatic von Hippel-Lindau abberations in sporadic renal cell carcinoma. Am, J. Hum. Genet. 55: 1092–1102.

    CAS  Google Scholar 

  13. Zbar B, Kishida T, Chen F, et al. (1996) Germline mutations in the von Hippel-Lindau (VHL) gene in families from North America, Europe, and Japan. Hum. Mutat. 8: 348–357.

    Article  CAS  PubMed  Google Scholar 

  14. Brauch H, Kishida T, Glavac D, et al. (1995) von Hippel-Lindau disease with pheochromocytoma in the Black Forest region in Germany: Evidence for a founder effect. Hum. Genet. 95: 551–556.

    Article  CAS  PubMed  Google Scholar 

  15. Neumann HPH, Wiestler OD (1991) Clustering of features of von Hippel-Lindau disease: Evidence of a complex genetic locus. Lancet 337: 1052–1054.

    Article  CAS  PubMed  Google Scholar 

  16. Glavac D, Neumann HPH, Wittke C, et al. (1996) Mutations in the VHL tumor suppressor gene and associated lesions in families with von Hippel-Lindau disease from central Europe. Hum. Genet. 98: 271–280.

    Article  CAS  PubMed  Google Scholar 

  17. Gross D, Avishai N, Meiner V, et al. (1996) Familial pheochromoccytoma associated with a novel mutation in the von Hippel-Lindau gene. J. Clin. Endocrinol. Metab. 81: 147–149.

    PubMed  CAS  Google Scholar 

  18. Ritter M, Frilling A, Crossey P, et al. (1996) Isolated familial pheochromocytoma as a variant of von Hippel-Lindau disease. J. Clin. Endocrinol. Metab. 81: 1035–1037.

    PubMed  CAS  Google Scholar 

  19. Neumann HPH, Berger DP, Sigmund G, et al. (1993) Pheochromocytomas, multiple endocrine neoplasia type 2, and von Hippel-Lindau disease. N. Engl. J. Med. 329: 1531–1538.

    Article  CAS  PubMed  Google Scholar 

  20. Gnarra JR, Tory K, Weng Y, et al. (1994) Mutations of the VHL tumour suppressor gene in renal carcinoma. Nat. Genet. 7: 85–90.

    Article  Google Scholar 

  21. Shuin T, Kondo K, Torigoe S, et al. (1994) Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumor suppressor gene in primary human renal cell carcinomas. Cancer Res. 54: 2852–2855.

    PubMed  CAS  Google Scholar 

  22. Herman JG, Latif F, Weng Y, et al. (1994) Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc. Natl. Acad. Sci. U.S.A. 91: 9700–9704.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  23. Foster K, Prowse A, van den Berg A, et al. (1994) Somatic mutations of the von Hippel-Lindau disease tumor suppressor gene in non-familial clear cell renal carcinoma. Hum. Mol. Genet. 3: 2169–2173.

    Article  CAS  PubMed  Google Scholar 

  24. Kanno H, Kondo K, Ito S, et al. (1994) Somatic mutations of the von Hippel-Lindau Tumor suppressor gene in sporadic central nervous systems hemangioblastomas. Cancer Res. 54: 4845–4847.

    PubMed  CAS  Google Scholar 

  25. Lubensky IA, Gnarra JR, Bertheau P, et al. (1996) Allelic deletions of the VHL gene detected in multiple microscopic clear cell renal lesions in von Hippel-Lindau disease patients. Am. J. Pathol. 149: 2089–2094.

    PubMed  PubMed Central  CAS  Google Scholar 

  26. Zhuang Z, Bertheau P, Emmert-Buck M, et al. (1995) A microscopic dissection technique for archival DNA analysis of specific cell populations in lesions <1 mm in size. Am. J. Pathol. 146: 620–625.

    PubMed  PubMed Central  CAS  Google Scholar 

  27. Hofstra RMW, Stelwagen T, Stulp RP, et al. (1996) Extensive mutation scanning of RET in sporadic medullary thyroid carcinoma and of RET and VHL in sporadic pheochromocytoma reveals involvement of these genes in only a minority of cases. J. Clin. Endocrinol. Metab. 81: 2881–2884.

    PubMed  CAS  Google Scholar 

  28. Nagashima Y, Miyagi Y, Udagawa K, et al. (1996) von Hippel-Lindau tumor suppressor gene. Localization of expression by in situ hybridization. J. Pathol. 180: 271–274.

    Article  CAS  PubMed  Google Scholar 

  29. Los M, Jansen GH, Kaelin WG, et al. (1996) Expression pattern of the von Hippel-Lindau protein in human tissues. Lab. Invest. 75: 231–238.

    PubMed  CAS  Google Scholar 

  30. Corless CL, Kibel A, Iliopoulos O, et al. (1997) Immunostaining of the von Hippel-Lindau gene product (pVHL) in normal and neoplastic human tissues. Hum. Pathol. 28: 459–464.

    Article  CAS  PubMed  Google Scholar 

  31. Lee S, Chen DYT, Humphrey JS, et al. (1996) Nuclear/cytoplasmic localization of the von Hippel-Lindau tumor suppressor gene product is determined by cell density. Proc. Natl. Acad. Sci. U.S.A. 93: 1770–1775.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  32. Gnarra JR, Zhou S, Merrill MJ, et al. (1996) Post-transcriptional regulation of vascular endothelial growth factor mRNA by the VHL tumor suppressor gene product. Proc. Natl. Acad. Sci. U.S.A. 93: 10589–10594.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  33. Chen F, Kishida T, Duh F-M, et al. (1995) Suppression of growth of renal carcinoma cells by the von Hippel-Lindau tumor suppressor gene. Cancer Res. 55: 4804–4807.

    PubMed  CAS  Google Scholar 

  34. Kibel A, Iliopoulos O, DeCaprio JD, et al. (1995) Binding of the von Hippel-Lindau tumor suppressor protein to elongin B and C. Science 269: 1444–1446.

    Article  CAS  PubMed  Google Scholar 

  35. Duan DR, Pause A, Burgress W, et al. (1995) Inhibition of transcription elongation by the VHL tumor suppressor protein. Science 269: 1402–1406.

    Article  CAS  PubMed  Google Scholar 

  36. Tsuchiya H, Iseda T, Hino O (1996) Identification of a novel protein (VBP-1) binding to the von Hippel-Lindau (VHL) tumor suppressor gene product. Cancer Res. 56: 2881–2885.

    PubMed  CAS  Google Scholar 

  37. Kishida T, Stackhouse TM, Chen F, et al. (1995) Cellular proteins that bind the von Hippel-Lindau disease gene product: Mapping of binding domains and the effect of missense mutations. Cancer Res. 55: 4544–4548.

    PubMed  CAS  Google Scholar 

  38. Aso T, Lane WS, Conaway JW, et al. (1995) Elongin (SIII): A multisubunit regulator of elongation by RNA polymerase II. Science 269: 1439–1443.

    Article  CAS  PubMed  Google Scholar 

  39. Iliopoulos O, Jiang C, Levy AP, et al. (1996) Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein. Proc. Natl. Acad. Sci. U.S.A. 93: 10595–10599.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  40. Siemeister G, Weindel K, Mohrs K, et al. (1996) Reversion of deregulated expression of vascular endothelial growth factor in human renal carcinoma cells by von Hippel-Lindau tumor suppressor protein. Cancer Res. 56: 2299–2301.

    PubMed  CAS  Google Scholar 

  41. Kolch W, Martiny-Baron G, Kieser A, et al. (1995) Regulation of the expression of the VEGF/VPS and its receptors: Role in tumor angiogenesis. Breast Cancer Res. Treat. 36: 139–155.

    Article  CAS  PubMed  Google Scholar 

  42. Levy AP, Levy NS, Iliopoulos O, et al. (1997) Regulation of vascular endothelial growth factor by hypoxia and its modulation by the von Hippel-Lindau tumor suppressor gene. Kidney Int. 51: 575–578.

    Article  CAS  PubMed  Google Scholar 

  43. Levy AP, Levy NS, Goldberg MA (1996) Hypoxia-inducible protein binding to vascular endothelial growth factor mRNA and its modulation by the von Hippel-Lindau protein. J. Biol. Chem. 271: 25492–25497.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We apologize to colleagues whose work was not cited due to space limitations. Othon Iliopoulos receives support from the Murray Foundation and the von Hippel-Lindau Family Alliance.

Author information

Authors and Affiliations

  1. Department of Medicine, Dana-Farber Cancer Institute and Harvard Medical School, Boston, 44 Binney Street, Massachusetts, 02115, USA

    Othon Iliopoulos & William G. Kaelin Jr.

Authors
  1. Othon Iliopoulos
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. William G. Kaelin Jr.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to William G. Kaelin Jr..

Rights and permissions

Reprints and permissions

About this article

Cite this article

Iliopoulos, O., Kaelin, W.G. The Molecular Basis of Von Hippel-Lindau Disease. Mol Med 3, 289–293 (1997). https://doi.org/10.1007/BF03401807

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03401807

Keywords

Search

Navigation